- Congressional Dietary Supplement Caucus hosts educational nutrient briefing on Capitol Hill
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- Report: Dietary supplements utilized as preventive health care can save health system tens of billions of dollars
- Study: 2,000 IUs of vitamin E daily effective in slowing functional decline in AD patients
- Overall, Okinawa Life passes muster with ERSP
NEW YORK — DrFuhrman.com on Monday informed the National Advertising Division that the company has discontinued certain advertising claims — including “anti-cancer” and cancer treatment claims — made for the company’s Immunotect dietary supplement.
The claims at issue were challenged by the Council for Responsible Nutrition.
NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.
As part of its routine monitoring program, and in conjunction with NAD’s initiative with CRN to expand the review of advertising claims made for supplements, NAD requested that DrFuhrman provide substantiation for more than a dozen claims.